Reghu Balakrishnan
Healthcare
US Court Rejects Taro's Appeal Against Sun Pharma In Takeover Battle
The never-ending battle between Sun Pharma and Israeli pharma firm, Taro Pharmaceutical Industries Ltd, seems to be nearing an end ......
Infrastructure
Swiss Chain, Xander Group To Launch Two Hotels In India
Swiss international hotel chain Swissôtel Hotels & Resorts has signed management contracts for two more hotels in India, the Swissôtel ......
General
SBI, Sultanate of Oman Set Up $100M PE Fund
State Bank of India, the largest public sector bank has entered into a joint venture agreement with State General Reserve ......
Healthcare
Piramal Sells Diagnostic Biz To Super Religare For Rs 600Cr
This is the second major business that Ajay Piramal-owned Piramal Healthcare has divested in recent months.Piramal Healthcare Limited has announced ......
Healthcare
Intel Capital Eyes Deals In Healthcare Space
Intel Capital, the corporate venture capital arm of chipmaker Intel Corporation, is expanding its investment horizon in India with exploring ......
Healthcare
Is Piramal Healthcare Now Shedding Diagnostics Biz?
The sellout story in the Indian healthcare industry continues. Piramal Healthcare, the flagship company owned by Ajay Piramal, is believed ......
General
'Agri & Food Industry To Grow To $280B In The Next 10 Years'
At the VCCircle ICICI bank Investment Summit in Mumbai, nearly 200 participants- drawn from the global investment community sported huge ......
General
Milestone Religare To Expand Focus With $200M Offshore Fund
Milestone Religare Investment Advisors Pvt. Ltd., the private equity joint venture between Milestone Capital and Religare Enterprises, is set to ......
General
Blue River Parts Ways With Edelweiss; Eyes $200M New Fund
Blue River Capital, a Mumbai-based PE firm, is in the process of raising its second fund (Blue River Capital II), ......
Healthcare
Pharma Firms Demerging Domestic Biz; Eyeing Better Valuation
With multinational pharma companies scouring for deals to tap the Rs 41,000-crore Indian pharma market, domestic firms are actively exploring ......